HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motomu Kuroki Selected Research

ATX 70

6/2007Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity.
5/2002Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motomu Kuroki Research Topics

Disease

35Neoplasms (Cancer)
01/2017 - 03/2002
5Carcinoma (Carcinomatosis)
12/2014 - 03/2002
3Adenocarcinoma of Lung
06/2008 - 06/2006
2Stomach Neoplasms (Stomach Cancer)
01/2017 - 06/2006
2Colorectal Neoplasms (Colorectal Cancer)
03/2009 - 11/2007
2Neoplasm Metastasis (Metastasis)
06/2008 - 11/2007
2Lymphatic Metastasis
06/2008 - 11/2007
1Carcinogenesis
03/2009
1Phototoxic Dermatitis (Phototoxicity)
06/2007
1Infections
06/2006
1Hypoxia (Hypoxemia)
06/2006
1Adenocarcinoma
06/2006
1Vitamin A Deficiency
01/2005
1Wounds and Injuries (Trauma)
03/2004
1Multiple Myeloma
01/2002
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2002

Drug/Important Bio-Agent (IBA)

14AntigensIBA
01/2015 - 03/2002
12Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2002
9Monoclonal AntibodiesIBA
12/2014 - 05/2002
9Carcinoembryonic AntigenIBA
12/2014 - 05/2002
4Interleukin-2 (IL2)IBA
01/2017 - 07/2002
4CytokinesIBA
01/2017 - 07/2002
4Single-Chain AntibodiesIBA
08/2014 - 03/2002
4LigandsIBA
06/2008 - 07/2004
4AntibodiesIBA
11/2006 - 11/2003
4Immunoglobulin G (IgG)IBA
06/2006 - 01/2002
3Epithelial Cell Adhesion MoleculeIBA
01/2015 - 12/2002
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2015 - 07/2010
3Photosensitizing Agents (Photosensitizers)IBA
12/2014 - 05/2002
3Complement System Proteins (Complement)IBA
01/2012 - 02/2004
3Messenger RNA (mRNA)IBA
03/2009 - 11/2007
3Peptides (Polypeptides)IBA
11/2005 - 11/2002
2Pharmaceutical PreparationsIBA
01/2012 - 11/2007
2Claudin-1IBA
03/2009 - 11/2007
2Tumor Biomarkers (Tumor Markers)IBA
11/2007 - 12/2002
2PorphyrinsIBA
06/2007 - 05/2002
2ATX 70IBA
06/2007 - 05/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2006 - 01/2005
2Neoplasm Antigens (Tumor Antigens)IBA
11/2005 - 07/2002
2EpitopesIBA
11/2003 - 11/2002
2Glycoproteins (Glycoprotein)IBA
07/2002 - 03/2002
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2017
1Chimeric Antigen ReceptorsIBA
01/2017
1LuciferasesIBA
12/2014
11-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2014
1Cell Adhesion MoleculesIBA
01/2012
1Chemokine ReceptorsIBA
06/2008
1ChemokinesIBA
06/2008
1Immunoglobulin A (IgA)IBA
01/2008
1Vascular Endothelial Growth Factor CIBA
11/2007
1adenovirus receptorIBA
11/2007
1EnzymesIBA
11/2007
1ImmunosorbentsIBA
11/2007
1RNA (Ribonucleic Acid)IBA
11/2007
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
11/2007
1Vascular Endothelial Growth Factor DIBA
11/2007
1ClaudinsIBA
11/2007
1Claudin-2IBA
11/2007
1Tight Junction ProteinsIBA
11/2007
1Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
11/2007
113,17- bis(1- carboxyethyl)- 8- (2- (2,4- dichlorophenylhydrazono)ethylidene)- 3- ethenyl- 7- hydroxy- 2,7,12,18- tetramethylchlorinIBA
06/2007
1Amino AcidsFDA Link
06/2006
1Recombinant ProteinsIBA
06/2006
1Immunoglobulin M (IgM)IBA
11/2005
1Immunoglobulin FragmentsIBA
11/2005
1Cancer VaccinesIBA
07/2004
1Thrombospondin 1IBA
03/2004
1Cadherins (E-Cadherin)IBA
12/2002
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
12/2002
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2002
1GalliumIBA
05/2002
1Recombinant Fusion ProteinsIBA
03/2002
1SuperantigensIBA
03/2002
1Indicators and Reagents (Reagents)IBA
03/2002

Therapy/Procedure

17Therapeutics
01/2017 - 03/2002
15Immunotherapy
01/2017 - 03/2002
2Photochemotherapy (Photodynamic Therapy)
12/2014 - 11/2007
1Lasers (Laser)
11/2007
1Intravenous Administration
05/2002